TY - JOUR
T1 - Off-pump coronary artery bypass grafting in a heparin-induced thrombocytopenia type II patient using hirudin
AU - Carr, C S
AU - Rayner, A
AU - Ponte, J
AU - Desai, J B
PY - 2005/2
Y1 - 2005/2
N2 - Heparin is routinely used for anticoagulation during cardiopulmonary bypass; it is fast acting, is easily monitored, and has an antidote. Heparin-induced thrombocytopenia (HIT) can be a life-threatening condition requiring an alternative anticoagulant (hirudin) if cardiac surgical intervention is considered. At full anticoagulant doses, the effects of hirudin are difficult to monitor; therefore, we present a case in which off-pump coronary artery bypass grafting was performed in an HIT patient in whom the lower doses of hirudin could safely be monitored with easily available tests. (C) 2005 by The Society of Thoracic Surgeons.
AB - Heparin is routinely used for anticoagulation during cardiopulmonary bypass; it is fast acting, is easily monitored, and has an antidote. Heparin-induced thrombocytopenia (HIT) can be a life-threatening condition requiring an alternative anticoagulant (hirudin) if cardiac surgical intervention is considered. At full anticoagulant doses, the effects of hirudin are difficult to monitor; therefore, we present a case in which off-pump coronary artery bypass grafting was performed in an HIT patient in whom the lower doses of hirudin could safely be monitored with easily available tests. (C) 2005 by The Society of Thoracic Surgeons.
U2 - 10.1016/j.athoracsur.2003.09.123
DO - 10.1016/j.athoracsur.2003.09.123
M3 - Article
VL - 79
SP - 696
EP - 698
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 2
ER -